Establishing Specification Acceptance Limits Consensus paper of the Working Group Drug Quality Control / Pharmaceutical Analytics of the German Pharmaceutical Society (DPhG)
نویسندگان
چکیده
The discussion started with a workshop on analytical uncertainty and rational specification setting in Frankfurt, January 31, 2002. As a conclusion of the presentations and discussion, a draft paper was published [1, 2] and accepted with some changes after a thorough discussion at the annual meeting of the Working Group Drug Quality Control / Pharmaceutical Analytics in October 2002 in Berlin [3].
منابع مشابه
Development of safety qualification thresholds and their use in orally inhaled and nasal drug product evaluation.
Safety thresholds for chemical impurities and leachables in consumer products such as foods and drugs have helped to ensure public health while establishing scientifically sound limits for identification and risk assessment of these compounds. The Product Quality Research Institute (PQRI) Leachables and Extractables Working Group, a collaboration of chemists and toxicologists from the U.S. Food...
متن کاملCombinative Particle Size Reduction Technologies for the Formulation of Poorly Soluble Drugs
1. Salazar, Jaime; Müller, Rainer H.; Möschwitzer, Jan P., (2009), “Systematic investigationto establish optimal process parameters for a novel particle size reduction method”, AnnualMeeting of the German Pharmaceutical Society (DPhG), Jena/Germany, September 28 –October 1, 2009. Poster presentation, abstract C48, booklet page 45. 2. Salazar, Jaime; Ghanem, Antoine; Müller, Rainer H...
متن کاملOverview of National Drug Policy of Iran
National Drug Policy (NDP) constitutes the specification of mid-term and long-term pharmaceutical objectives by the government and the determination of major strategies warranted to achieve such objectives. Stated in other words, NDP determines the frameworks for the pharmaceutical activities of private and state sectors. The specification of these policies and strategies will be an effective m...
متن کاملOverview of National Drug Policy of Iran
National Drug Policy (NDP) constitutes the specification of mid-term and long-term pharmaceutical objectives by the government and the determination of major strategies warranted to achieve such objectives. Stated in other words, NDP determines the frameworks for the pharmaceutical activities of private and state sectors. The specification of these policies and strategies will be an effective m...
متن کاملPage 1 of 42 Quality by Design Specifications for Solid Oral Dosage Forms: Multivariate Product and Process Monitoring for Managing Drug Quality Attributes by the Specification Design and Lifecycle Management Working Group of the PQRI Manufacturing Technical Committee Preamble
The purpose of this paper is to stimulate discussion around the thought processes and activities that occur from creation through development and commercialization of a molecule that ultimately becomes a drug product that benefits patients. This includes exploring the scientific evidence and pharmacological underpinnings that link clinical concepts to drug product design, manufacturing controls...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2003